Medarex About
Medarex Medarex is a biopharmaceutical company focused on the
discovery and development of fully human antibody-based therapeutics to treat
life- threatening and debilitating diseases, including cancer, inflammation, autoimmune
and infectious diseases. Medarex applies its UltiMAb® technology and product development
and clinical manufacturing experience to generate, support and potentially commercialize
a broad range of fully human antibody products for itself and its partners. Medarex
is committed to building value by developing a diverse pipeline of antibody products
to address the world's unmet healthcare needs. Scientific
Publications from Medarex More
on Medarex